VENTRICULAR REMODELLING

This adverse event was reported 72 times

VENTRICULAR REMODELLING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMLODIPINE AND ATORVASTATIN 4 0.0010
1 ERTUGLIFLOZIN 1 0.0009
2 CHLORTHALIDONE 4 0.0003
3 DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 1 0.0003
4 TACROLIMUS OINTMENT 0.1% 28 0.0002
5 TACROLIMUS EXTENDED-RELEASE CAPSULES 28 0.0002
6 MYCOPHENILIC ACID 4 0.0002
7 TACROLIMUS 28 0.0002
8 CEFAZOLIN SODIUM 2 0.0002
9 MYCOPHENOLATE MOFETIL 19 0.0001
See all drugs enriched for association with VENTRICULAR REMODELLING